Fingerprint
Dive into the research topics of 'Obatoclax mesylate, a pan-Bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically